Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Hydrogen peroxide and monoethanolamine in hair dye can cause dermatitis and hair loss.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Human hair follicle stem cells show signs of low oxygen levels, which may be important for hair growth and preventing baldness.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Finasteride effectively treats male hair loss, improving growth and density.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Cetuximab can cause eyelash growth, which is rare but manageable.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Oral zinc sulphate reduces dark hair color in mice.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Transcutol® helps drugs penetrate the skin more effectively in various formulations.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

New lipid nanoparticles show promise for delivering hair loss treatments but need improvement for better skin penetration.

Early hair loss may indicate prostate issues.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.